<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01050166</url>
  </required_header>
  <id_info>
    <org_study_id>CD MRI IKEM 1</org_study_id>
    <nct_id>NCT01050166</nct_id>
  </id_info>
  <brief_title>MRI Imaging of Labeled Human Islets Transplanted Into the Liver</brief_title>
  <official_title>Phase 1 Study to Test Safety and Efficacy of Magnetic Resonance Imaging of Human Labeled Islets Transplanted Into the Liver in Type 1 Diabetic Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute for Clinical and Experimental Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute for Clinical and Experimental Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether human islets labeled by iron contrast agents
      could be imaged using magnetic resonance after transplantation into the liver of Type 1
      diabetic recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Islet transplantation represents approved therapeutic approach in selected Type 1 diabetic
      recipients with syndrome of hypoglycaemia unawareness. Existing imaging methods are not
      sufficient to provide adequate information about amount and fate of islets transplanted into
      the liver. Labeling of islets with superparamagnetic contrast agent ferucarbotran
      significantly shortens T2 relaxing time and therefore increase the contrast between islets
      and liver tissue in magnetic resonance imaging. In consequence, islets transplanted into
      liver could be easily detectable like hypotensive areas dispersed throughout the liver. MRI
      examination will be done on 1, 2, 4 weeks and 3, 6 and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of safety and efficacy of MRI imaging of transplanted human labeled islets</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Labeled islets</arm_group_label>
    <description>Type 1 diabetic recipients after islet transplantation with islets labeled by iron contrast agent</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transplantation of labeled islets</intervention_name>
    <arm_group_label>Labeled islets</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort will be selected from residents of Czech republic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes mellitus

          -  normal renal parameters

          -  hypoglycaemia unawareness or rapid progression of diabetic retinopathy or neuropathy

        Exclusion Criteria:

          -  acute and chronic liver disease

          -  malignancy

          -  acute infection

          -  serious cardiovascular disease

          -  coagulopathy

          -  portal hypertension

          -  presence of metal protesis, cardio-stimulators, or other metal material in the body
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frantisek Saudek, MD, DrSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Clinical and Experimental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frantisek Saudek, MD, DrSc</last_name>
    <phone>+420261364107</phone>
    <email>frsa@ikem.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diabetes Center, Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>14000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saudek</last_name>
      <phone>+420261364107</phone>
      <email>frsa@ikem.cz</email>
    </contact>
    <investigator>
      <last_name>Frantisek Saudek, MD, DrSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milan Hajek</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Girman, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monika Dezortova</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2010</study_first_submitted>
  <study_first_submitted_qc>January 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2010</study_first_posted>
  <last_update_submitted>January 14, 2010</last_update_submitted>
  <last_update_submitted_qc>January 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Doc. MUDr.Jan Maly CSc</name_title>
    <organization>Institute for Clinical and Experimental Medicine</organization>
  </responsible_party>
  <keyword>islet transplantation</keyword>
  <keyword>magnetic resonance</keyword>
  <keyword>Type 1 DM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

